Many physicians are worried about Sunshine Act implications


Physicians and clinical trial investigators are concerned that the Sunshine Act will have a negative effect on their practices, according to a recent study conducted by Industry Standard Research. Additionally, ISR found that 74% of physicians surveyed said they were not in favor of making data about industry-physician relationships public; others said they likely would reduce the amount of time they spend in group detail sessions after Sunshine Act implementation. "If physicians are concerned that interacting with the pharmaceuticals industry has a negative connotation, there could be a chilling effect on those relationships, which are vital to the public health," said Coalition for Healthcare Communication Executive Director John Kamp. "The Sunshine Act is supposed to lend transparency to these relationships, not undermine them," Kamp said. Read more.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA